Last reviewed · How we verify
montelukast and levocetirizine FDC — Competitive Intelligence Brief
phase 1
Small molecule
Live · refreshed every 30 min
Target snapshot
montelukast and levocetirizine FDC (montelukast and levocetirizine FDC) — Hanmi Pharmaceutical Company Limited.
Comparator set
| Drug | Generic | Sponsor | Phase | Class | Target | Approval / PDUFA |
|---|---|---|---|---|---|---|
| montelukast and levocetirizine FDC TARGET | montelukast and levocetirizine FDC | Hanmi Pharmaceutical Company Limited | phase 1 |
Recent regulatory actions (last 90 days)
Upcoming PDUFA dates (next 180 days)
Patent timeline (forward window)
Sponsor landscape
Subscribe to ongoing alerts
Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:
- montelukast and levocetirizine FDC CI watch — RSS
- montelukast and levocetirizine FDC CI watch — Atom
- montelukast and levocetirizine FDC CI watch — JSON
- montelukast and levocetirizine FDC alone — RSS
Cite this brief
Drug Landscape (2026). montelukast and levocetirizine FDC — Competitive Intelligence Brief. https://druglandscape.com/ci/montelukast-and-levocetirizine-fdc. Accessed 2026-05-17.
Build your own brief
Pick any drug + add comparators:
https://druglandscape.com/ci/{slug}— auto-detected competitorshttps://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3— explicit comparators- Brand names auto-resolve:
/ci/keytruda→ 301 →/ci/pembrolizumab